Eric I. Marks, MD Hear my name
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Hematology & Medical Oncology

MD, Pennsylvania State College of Medicine
BS, University of Massachusetts Worcester

Dr. Eric Marks is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine. He currently specializes in gastrointestinal oncology and sarcomas. Dr. Marks graduated from the University of Massachusetts and subsequently pursued medical school and a residency in Internal Medicine at Pennsylvania State University. He then completed his fellowship in hematology and medical oncology at the Warren Alpert Medical School of Brown University, where he published several studies focused on gastrointestinal malignancies.

Diversity, Equity, Inclusion and Accessibility

I am part of a dedicated team of healthcare professionals, researchers, students and staff from different countries and various regions of the U.S. The culture of our Section is defined by the unique perspectives that we each bring with us. As both a large academic medical center and safety-net hospital serving the communities of Boston and its surroundings, our trainees engage in cutting edge research and gain real-world clinical experience by caring for local underserved populations. Our multilingual team is committed to promoting cultural competency, equity and inclusion in science, medicine and healthcare. We strive to maintain a workforce that is as diverse as the communities we serve, and aim to create a safe space for our members to learn, grow and succeed in their life goals. Acknowledging that we all have a role to play, I am dedicated to welcoming and celebrating individuals of all races, ethnicities, social backgrounds, religion, gender, sex, age, ability, sexual orientation, veteran status, and national origin.

Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma
04/01/2023 - 03/31/2028 (PI)
EMMES Corporation

HCRN GI19-405
02/23/2022 - 02/22/2024 (PI)
Hoosier Cancer Research Network, Inc.


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Marks EI, Matera R, Olszewski AJ, Yakirevich E, El-Deiry WS, Safran H, Carneiro BA. Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens. Am J Clin Oncol. 2021 02 01; 44(2):68-73. PMID: 33298767
  2. Marks EI, Brown VS, Dizon DS. Am J Clin Oncol. Genomic and Molecular Abnormalities in Gynecologic Clear Cell Carcinoma. 2020; 43(2):139-145.
  3. Marks EI, Ollila TA. Acanthocytosis causing chronic hemolysis in a patient with advanced cirrhosis. Blood. 2019; 133:1518.
  4. Marks EI, Pamarthy S, Dizon D, Birnbaum A, Yakirevich E, Safran H, Carneiro B. ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma. Oncotarget. 2019; 10:245-251.
  5. Lipton A, Leitzel K, Ali SM, Polimera HV, Nagabhairu V, Marks E, Richardson AE, Krecko L, Ali A, Koestler W, Esteva FJ, Leeming DJ, Karsdal MA, Willumsen N. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. Int J Cancer. 2018 12 01; 143(11):3027-3034. PMID: 29923614; DOI: 10.1002/ijc.31627;
  6. Yacur M, Marks EI, Suleski J, Joshi M. Expression of Beta-Human Chorionic Gonadotropin (BetaHCG) in Transitional Cell Carcinoma. Annals of Carcinogenesis. 2017; 2(2):1012-1016.
  7. Marks EI, Yee NS. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World J Gastroenterol. 2016 Jan 28; 22(4):1335-47. PMID: 26819503; PMCID: PMC4721969; DOI: 10.3748/wjg.v22.i4.1335;
  8. Marks EI, Yee NS. World J of Gastroenterol. Molecular genetics and targeted therapeutics in biliary tract carcinoma. 2016; 22(4):1335-1347.
  9. Marks EI, Yee NS. Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies. World J Gastrointest Oncol. 2015 Nov 15; 7(11):338-46. PMID: 26600933; PMCID: PMC4644856; DOI: 10.4251/wjgo.v7.i11.338;
  10. Marks EI, Yee NS. Curr Cancer Drug Targets. Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma. 2015; 16:53-70.
Showing 10 of 15 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 15 publications over 7 distinct years, with a maximum of 7 publications in 2015


2019 Brown University: Certificate of exemplary teaching
2016 Penn State Cancer Institute house-staff award for clinical performance
Contact for Mentoring:
Marks's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department